𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Paget's disease of bone: Five regimens of pamidronate treatment

✍ Scribed by T. Pepersack; R. Karmali; C. Gillet; D. François; M. Fuss

Publisher
Springer
Year
1994
Tongue
English
Weight
500 KB
Volume
13
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Goals of treatment for paget's disease o
Goals of treatment for paget's disease of bone
✍ Ethel S. Siris 📂 Article 📅 1999 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 466 KB 👁 1 views

The goals of treatment of Paget's disease must be readdressed in the context of the availability of potent bsphosphonate compounds, including pamidronate and, more recently, alendronate and risedronate. These agents differ from the traditional mainstays of therapy, salmon calcitonin and etidmnate, i

Comparison of intravenous and intramuscu
Comparison of intravenous and intramuscular neridronate regimens for the treatment of paget disease of bone
✍ Daniela Merlotti; Domenico Rendina; Luigi Gennari; Giuseppe Mossetti; Fernando G 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 193 KB 👁 1 views

## Abstract Aminobisphosphonates actually represent the most common treatment for Paget disease of bone (PDB). In a previous study we demonstrated that either zoledronic acid (4 mg) or neridronate (200 mg) given as a single intravenous infusion showed a similar short‐term efficacy in achieving bioc